Global Smart Inhaler Technology Market By Inhaler Type (Breath-actuated MDIs (metered-dose inhalers), DPIs (dry powder inhalers), Propellant-free multi-dose spray inhalers); By Indication (Asthma, COPD, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By End User (Kids, Adults); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global smart inhaler technology market was valued is witnessing CAGR of 25.2% over the forecast period (2022 – 2030). Breathing-related diseases are on a rise due to several factors, majorly pollution and climatic changes. Presence of harmful allergens in the air along with pollutants is the reason why numerous people are being infected. The number of people suffering from asthma and other breathing disorders have found solace in various type of inhalers. These inhalers are easily available and are capable of providing instant relief, ultimately making life easier for the patients. All these factors contribute to the growth of this market.
The growth of the global smart inhaler technology market went up in the times of COVID-19 pandemic. As the novel SARS-CoV-2 virus was directly infecting the respiratory organs, people with breathing disorder were likely to get infected. This caused a spike in the demand for inhalers and taking the growth of this market to new heights.
Inhaler Type Outlook
On the basis of inhaler type, the global smart inhaler technology market has been divided into breath-actuated MDIs (metered-dose inhalers), DPIs (dry powder inhalers) and propellant-free multi-dose spray inhalers. The breath-actuated MDIs (metered-dose inhalers) segment generates most of the revenue for this market. This type of inhalers are not only easily available but also extremely easy to use in case of any emergency. They also have a counter which notifies the user regarding balance number of doses, which proves helpful every time they are running out of the medicine.
Indication Outlook
On the basis of indication, the global smart inhaler technology market has been segmented into asthma, COPD, and others. The asthma segment accounts for majority of revenue generated by this market. People suffering from asthma are constantly rising due to changing climatic conditions. Extensive use of chemical-based fertilizers is also impacting one’s immunity, which also makes them allergic.
Global Smart Inhaler Technology Market Revenue & Forecast, (US$ Million), 2022 – 2030
Distribution Channel Outlook
The distribution channel of the global smart inhaler technology market has been segregated into hospital pharmacies, retail pharmacies and online pharmacies. At present, the retail pharmacies are generating maximum amount of revenue for this market. Patients using inhalers require it regularly and their always go-to-pharmacy store is aware of their needs. Easy availability makes this segment gain edge over its competitors. On the other hand, the online pharmacies are forecasted to generate revenue at the fastest rate.
End User Outlook
The end user segment of the global smart inhaler technology market has been divided into kids and adults. Breathing disorders like asthma are more likely to become serious over the period of time, especially in the elder age. This is the basic reason why adults majorly contribute to the growth of this market. In today’s fast-paced life, inhaler is not just easy but also a mandatory medical equipment for asthmatic people or those with breathing issues.
Region Outlook
On the basis of region, North America generates the highest amount of revenue for global smart inhaler technology market. Degrading lifestyle along with excessive low-quality/ less nutritional food is making more people more to chronic diseases like asthma. Deteriorating immune system due to unhealthy and sedentary lifestyle is impacting health of majority of Americans state several surveys, and this is immensely helping this market to grow in the region.
Competitive Landscape
The report provides both, qualitative and quantitative research of global smart inhaler technology market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
A few of the major players operating in the global smart inhaler technology market are listed below:
- Adherium
- Aptar Group Inc.
- Herotracker
- AstraZeneca Inc.
- Haler
- BreatheSuite Inc.
- Cognita Labs
- Findair Sp. Zo. O
- GlaxoSmithKline Plc
- Gets
- Novartis AG
- OPKO Health Inc.
- Next generation
- Philip Morris International Inc. (Vectura Group Plc)
- ResMed Inc.
- Sensirion AG
- Teva Pharmaceutical Industries Ltd.
- Other Market Participants
Global Smart Inhaler Technology Market
By Inhaler Type
- Breath-actuated MDIs (metered-dose inhalers)
- DPIs (dry powder inhalers)
- Propellant
By Indication
- Asthma
- COPD
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By End User
- Adults
- Kids
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2020
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 – 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Smart Inhaler Technology Market
6. Market Synopsis: Smart
Inhaler Technology Market
7. Smart Inhaler Technology Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Smart Inhaler Technology Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Smart Inhaler Technology Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Smart Inhaler Technology Market
8. Global Smart Inhaler Technology Market Analysis and
Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global
Smart Inhaler Technology Market Revenue (US$ Mn)
8.2. Global
Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By Inhaler Type
8.2.1. Breath-actuated
MDIs (Metered-Dose Inhalers)
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2021
8.2.1.3. Market Forecast, 2022 – 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2021
8.2.1.5.1.2. Market
Forecast, 2022 – 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2021
8.2.1.5.2.2. Market
Forecast, 2022 – 2030
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2021
8.2.1.5.3.2. Market
Forecast, 2022 – 2030
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2021
8.2.1.5.4.2. Market
Forecast, 2022 – 2030
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2021
8.2.1.5.5.2. Market
Forecast, 2022 – 2030
8.2.2. DPIs
(Dry Powder Inhalers)
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2021
8.2.2.3. Market Forecast, 2022 – 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 – 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 – 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 – 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 – 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 – 2030
8.2.3. Propellant-free
multi-dose spray inhalers.
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2021
8.2.3.3. Market Forecast, 2022 – 2030
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2021
8.2.3.5.1.2. Market
Forecast, 2022 – 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2021
8.2.3.5.2.2. Market
Forecast, 2022 – 2030
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2021
8.2.3.5.3.2. Market
Forecast, 2022 – 2030
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2021
8.2.3.5.4.2. Market
Forecast, 2022 – 2030
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2021
8.2.3.5.5.2. Market
Forecast, 2022 – 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Inhaler Type
9. Global Smart Inhaler Technology Market Analysis and
Forecasts, 2022 – 2030
9.1. Overview
9.2. Global
Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By Indication
9.2.1. Asthma
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2021
9.2.1.3. Market Forecast, 2022 – 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 – 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 – 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 – 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 – 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 – 2030
9.2.2. COPD
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2021
9.2.2.3. Market Forecast, 2022 – 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 – 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 – 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 – 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 – 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 – 2030
9.2.3. Others
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2021
9.2.3.3. Market Forecast, 2022 – 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 – 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 – 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 – 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 – 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 – 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By Indication
10. Global Smart Inhaler Technology Market Analysis and
Forecasts, 2022 – 2030
10.1. Overview
10.2. Global
Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
10.2.1. Hospital
Pharmacies
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2021
10.2.1.3. Market Forecast, 2022 – 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2021
10.2.1.5.1.2. Market
Forecast, 2022 – 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2021
10.2.1.5.2.2. Market
Forecast, 2022 – 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2021
10.2.1.5.3.2. Market
Forecast, 2022 – 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2021
10.2.1.5.4.2. Market
Forecast, 2022 – 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2021
10.2.1.5.5.2. Market
Forecast, 2022 – 2030
10.2.2. Retail
Pharmacies
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2021
10.2.2.3. Market Forecast, 2022 – 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022 – 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022 – 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 – 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022 – 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022 – 2030
10.2.3. Online
pharmacies
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2021
10.2.3.3. Market Forecast, 2022 – 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2021
10.2.3.5.1.2. Market
Forecast, 2022 – 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2021
10.2.3.5.2.2. Market
Forecast, 2022 – 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2021
10.2.3.5.3.2. Market
Forecast, 2022 – 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2021
10.2.3.5.4.2. Market
Forecast, 2022 – 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2021
10.2.3.5.5.2. Market
Forecast, 2022 – 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By
Distribution Channel
11. Global Smart Inhaler Technology Market Analysis and
Forecasts, 2022 – 2030
11.1. Overview
11.2. Global
Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By End User
11.2.1. Kids
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2021
11.2.1.3. Market Forecast, 2022 – 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022 – 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022 – 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2021
11.2.1.5.3.2. Market
Forecast, 2022 – 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022 – 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022 – 2030
11.2.2. Adults
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2021
11.2.2.3. Market Forecast, 2022 – 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022 – 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2021
11.2.2.5.3.2. Market
Forecast, 2022 – 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022 – 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022 – 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By End
User
12. North America Smart Inhaler Technology Market Analysis and
Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North America
Smart Inhaler Technology Market Revenue (US$ Mn)
12.2. North
America Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By
Inhaler Type
12.2.1. Breath-actuated
MDIs (Metered-Dose Inhalers)
12.2.2. DPIs
(Dry Powder Inhalers)
12.2.3. Propellant-free
multi-dose spray inhalers.
12.3. North
America Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By Indication
12.3.1. Asthma
12.3.2. COPD
12.3.3. Others
12.4. North
America Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
12.4.1. Hospital
Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online
pharmacies
12.5. North
America Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By End
User
12.5.1. Kids
12.5.2. Adults
12.6. North
America Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By
Country
12.6.1. U.S
12.6.1.1. U.S Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
12.6.1.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
12.6.1.1.2. DPIs (Dry Powder Inhalers)
12.6.1.1.3. Propellant-free multi-dose spray inhalers.
12.6.1.2. U.S Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
12.6.1.2.1. Asthma
12.6.1.2.2. COPD
12.6.1.2.3. Others
12.6.1.3. U.S Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
12.6.1.3.1. Hospital Pharmacies
12.6.1.3.2. Retail Pharmacies
12.6.1.3.3. Online pharmacies
12.6.1.4. U.S Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.1.4.1. Kids
12.6.1.4.2. Adults
12.6.2. Canada
12.6.2.1. Canada Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
12.6.2.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
12.6.2.1.2. DPIs (Dry Powder Inhalers)
12.6.2.1.3. Propellant-free multi-dose spray inhalers.
12.6.2.2. Canada Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
12.6.2.2.1. Asthma
12.6.2.2.2. COPD
12.6.2.2.3. Others
12.6.2.3. Canada Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
12.6.2.3.1. Hospital Pharmacies
12.6.2.3.2. Retail Pharmacies
12.6.2.3.3. Online pharmacies
12.6.2.4. Canada Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.2.4.1. Kids
12.6.2.4.2. Adults
12.6.3. Mexico
12.6.3.1. Mexico Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
12.6.3.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
12.6.3.1.2. DPIs (Dry Powder Inhalers)
12.6.3.1.3. Propellant-free multi-dose spray inhalers.
12.6.3.2. Mexico Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
12.6.3.2.1. Asthma
12.6.3.2.2. COPD
12.6.3.2.3. Others
12.6.3.3. Mexico Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
12.6.3.3.1. Hospital Pharmacies
12.6.3.3.2. Retail Pharmacies
12.6.3.3.3. Online pharmacies
12.6.3.4. Mexico Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.3.4.1. Kids
12.6.3.4.2. Adults
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By Inhaler Type
12.6.4.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
12.6.4.1.2. DPIs (Dry Powder Inhalers)
12.6.4.1.3. Propellant-free multi-dose spray inhalers.
12.6.4.2. Rest of North America Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By Indication
12.6.4.2.1. Asthma
12.6.4.2.2. COPD
12.6.4.2.3. Others
12.6.4.3. Rest of North America Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
12.6.4.3.1. Hospital Pharmacies
12.6.4.3.2. Retail Pharmacies
12.6.4.3.3. Online pharmacies
12.6.4.4. Rest of North America Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By End User
12.6.4.4.1. Kids
12.6.4.4.2. Adults
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Inhaler Type
12.7.3. By Indication
12.7.4. By
Distribution Channel
12.7.5. By End
User
13. Europe Smart Inhaler Technology Market Analysis and
Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe
Smart Inhaler Technology Market Revenue (US$ Mn)
13.2. Europe
Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By Inhaler Type
13.2.1. Breath-actuated
MDIs (Metered-Dose Inhalers)
13.2.2. DPIs
(Dry Powder Inhalers)
13.2.3. Propellant-free
multi-dose spray inhalers.
13.3. Europe
Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By Indication
13.3.1. Asthma
13.3.2. COPD
13.3.3. Others
13.4. Europe
Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.4.1. Hospital
Pharmacies
13.4.2. Retail
Pharmacies
13.4.3. Online
pharmacies
13.5. Europe
Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By End User
13.5.1. Kids
13.5.2. Adults
13.6. Europe
Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
13.6.1.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
13.6.1.1.2. DPIs (Dry Powder Inhalers)
13.6.1.1.3. Propellant-free multi-dose spray inhalers.
13.6.1.2. France Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
13.6.1.2.1. Asthma
13.6.1.2.2. COPD
13.6.1.2.3. Others
13.6.1.3. France Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.1.3.1. Hospital Pharmacies
13.6.1.3.2. Retail Pharmacies
13.6.1.3.3. Online pharmacies
13.6.1.4. France Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.1.4.1. Kids
13.6.1.4.2. Adults
13.6.2. The UK
13.6.2.1. The UK Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
13.6.2.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
13.6.2.1.2. DPIs (Dry Powder Inhalers)
13.6.2.1.3. Propellant-free multi-dose spray inhalers.
13.6.2.2. The UK Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
13.6.2.2.1. Asthma
13.6.2.2.2. COPD
13.6.2.2.3. Others
13.6.2.3. The UK Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.2.3.1. Hospital Pharmacies
13.6.2.3.2. Retail Pharmacies
13.6.2.3.3. Online pharmacies
13.6.2.4. The UK Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.2.4.1. Kids
13.6.2.4.2. Adults
13.6.3. Spain
13.6.3.1. Spain Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
13.6.3.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
13.6.3.1.2. DPIs (Dry Powder Inhalers)
13.6.3.1.3. Propellant-free multi-dose spray inhalers.
13.6.3.2. Spain Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
13.6.3.2.1. Asthma
13.6.3.2.2. COPD
13.6.3.2.3. Others
13.6.3.3. Spain Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.3.3.1. Hospital Pharmacies
13.6.3.3.2. Retail Pharmacies
13.6.3.3.3. Online pharmacies
13.6.3.4. Spain Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.3.4.1. Kids
13.6.3.4.2. Adults
13.6.4. Germany
13.6.4.1. Germany Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
13.6.4.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
13.6.4.1.2. DPIs (Dry Powder Inhalers)
13.6.4.1.3. Propellant-free multi-dose spray inhalers.
13.6.4.2. Germany Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
13.6.4.2.1. Asthma
13.6.4.2.2. COPD
13.6.4.2.3. Others
13.6.4.3. Germany Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.4.3.1. Hospital Pharmacies
13.6.4.3.2. Retail Pharmacies
13.6.4.3.3. Online pharmacies
13.6.4.4. Germany Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.4.4.1. Kids
13.6.4.4.2. Adults
13.6.5. Italy
13.6.5.1. Italy Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
13.6.5.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
13.6.5.1.2. DPIs (Dry Powder Inhalers)
13.6.5.1.3. Propellant-free multi-dose spray inhalers.
13.6.5.2. Italy Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
13.6.5.2.1. Asthma
13.6.5.2.2. COPD
13.6.5.2.3. Others
13.6.5.3. Italy Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.5.3.1. Hospital Pharmacies
13.6.5.3.2. Retail Pharmacies
13.6.5.3.3. Online pharmacies
13.6.5.4. Italy Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.5.4.1. Kids
13.6.5.4.2. Adults
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By Inhaler Type
13.6.6.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
13.6.6.1.2. DPIs (Dry Powder Inhalers)
13.6.6.1.3. Propellant-free multi-dose spray inhalers.
13.6.6.2. Nordic Countries Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By Indication
13.6.6.2.1. Asthma
13.6.6.2.2. COPD
13.6.6.2.3. Others
13.6.6.3. Nordic Countries Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
13.6.6.3.1. Hospital Pharmacies
13.6.6.3.2. Retail Pharmacies
13.6.6.3.3. Online pharmacies
13.6.6.4. Nordic Countries Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By End User
13.6.6.4.1. Kids
13.6.6.4.2. Adults
13.6.6.5. Nordic Countries Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Inhaler Type
13.6.7.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
13.6.7.1.2. DPIs (Dry Powder Inhalers)
13.6.7.1.3. Propellant-free multi-dose spray inhalers.
13.6.7.2. Benelux Union Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Indication
13.6.7.2.1. Asthma
13.6.7.2.2. COPD
13.6.7.2.3. Others
13.6.7.3. Benelux Union Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
13.6.7.3.1. Hospital Pharmacies
13.6.7.3.2. Retail Pharmacies
13.6.7.3.3. Online pharmacies
13.6.7.4. Benelux Union Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.7.4.1. Kids
13.6.7.4.2. Adults
13.6.7.5. Benelux Union Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By Inhaler Type
13.6.8.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
13.6.8.1.2. DPIs (Dry Powder Inhalers)
13.6.8.1.3. Propellant-free multi-dose spray inhalers.
13.6.8.2. Rest of Europe Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By Indication
13.6.8.2.1. Asthma
13.6.8.2.2. COPD
13.6.8.2.3. Others
13.6.8.3. Rest of Europe Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
13.6.8.3.1. Hospital Pharmacies
13.6.8.3.2. Retail Pharmacies
13.6.8.3.3. Online pharmacies
13.6.8.4. Rest of Europe Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By End User
13.6.8.4.1. Kids
13.6.8.4.2. Adults
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Inhaler Type
13.7.3. By Indication
13.7.4. By
Distribution Channel
13.7.5. By End
User
14. Asia Pacific Smart Inhaler Technology Market Analysis and
Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia
Pacific Smart Inhaler Technology Market Revenue (US$ Mn)
14.2. Asia
Pacific Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By
Inhaler Type
14.2.1. Breath-actuated
MDIs (Metered-Dose Inhalers)
14.2.2. DPIs
(Dry Powder Inhalers)
14.2.3. Propellant-free
multi-dose spray inhalers.
14.3. Asia
Pacific Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By Indication
14.3.1. Asthma
14.3.2. COPD
14.3.3. Others
14.4. Asia
Pacific Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.4.1. Hospital
Pharmacies
14.4.2. Retail
Pharmacies
14.4.3. Online
pharmacies
14.5. Asia
Pacific Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By End
User
14.5.1. Kids
14.5.2. Adults
14.6. Asia
Pacific Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By
Country
14.6.1. China
14.6.1.1. China Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
14.6.1.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
14.6.1.1.2. DPIs (Dry Powder Inhalers)
14.6.1.1.3. Propellant-free multi-dose spray inhalers.
14.6.1.2. China Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
14.6.1.2.1. Asthma
14.6.1.2.2. COPD
14.6.1.2.3. Others
14.6.1.3. China Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.1.3.1. Hospital Pharmacies
14.6.1.3.2. Retail Pharmacies
14.6.1.3.3. Online pharmacies
14.6.1.4. China Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.1.4.1. Kids
14.6.1.4.2. Adults
14.6.2. Japan
14.6.2.1. Japan Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
14.6.2.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
14.6.2.1.2. DPIs (Dry Powder Inhalers)
14.6.2.1.3. Propellant-free multi-dose spray inhalers.
14.6.2.2. Japan Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
14.6.2.2.1. Asthma
14.6.2.2.2. COPD
14.6.2.2.3. Others
14.6.2.3. Japan Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.2.3.1. Hospital Pharmacies
14.6.2.3.2. Retail Pharmacies
14.6.2.3.3. Online pharmacies
14.6.2.4. Japan Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.2.4.1. Kids
14.6.2.4.2. Adults
14.6.3. India
14.6.3.1. India Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
14.6.3.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
14.6.3.1.2. DPIs (Dry Powder Inhalers)
14.6.3.1.3. Propellant-free multi-dose spray inhalers.
14.6.3.2. India Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
14.6.3.2.1. Asthma
14.6.3.2.2. COPD
14.6.3.2.3. Others
14.6.3.3. India Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.3.3.1. Hospital Pharmacies
14.6.3.3.2. Retail Pharmacies
14.6.3.3.3. Online pharmacies
14.6.3.4. India Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.3.4.1. Kids
14.6.3.4.2. Adults
14.6.4. New
Zealand
14.6.4.1. New Zealand Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Inhaler Type
14.6.4.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
14.6.4.1.2. DPIs (Dry Powder Inhalers)
14.6.4.1.3. Propellant-free multi-dose spray inhalers.
14.6.4.2. New Zealand Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Indication
14.6.4.2.1. Asthma
14.6.4.2.2. COPD
14.6.4.2.3. Others
14.6.4.3. New Zealand Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
14.6.4.3.1. Hospital Pharmacies
14.6.4.3.2. Retail Pharmacies
14.6.4.3.3. Online pharmacies
14.6.4.4. New Zealand Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By End User
14.6.4.4.1. Kids
14.6.4.4.2. Adults
14.6.5. Australia
14.6.5.1. Australia Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
14.6.5.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
14.6.5.1.2. DPIs (Dry Powder Inhalers)
14.6.5.1.3. Propellant-free multi-dose spray inhalers.
14.6.5.2. Australia Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
14.6.5.2.1. Asthma
14.6.5.2.2. COPD
14.6.5.2.3. Others
14.6.5.3. Australia Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.5.3.1. Hospital Pharmacies
14.6.5.3.2. Retail Pharmacies
14.6.5.3.3. Online pharmacies
14.6.5.4. Australia Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.5.4.1. Kids
14.6.5.4.2. Adults
14.6.6. South
Korea
14.6.6.1. South Korea Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Inhaler Type
14.6.6.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
14.6.6.1.2. DPIs (Dry Powder Inhalers)
14.6.6.1.3. Propellant-free multi-dose spray inhalers.
14.6.6.2. South Korea Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Indication
14.6.6.2.1. Asthma
14.6.6.2.2. COPD
14.6.6.2.3. Others
14.6.6.3. South Korea Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
14.6.6.3.1. Hospital Pharmacies
14.6.6.3.2. Retail Pharmacies
14.6.6.3.3. Online pharmacies
14.6.6.4. South Korea Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By End User
14.6.6.4.1. Kids
14.6.6.4.2. Adults
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By Inhaler Type
14.6.7.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
14.6.7.1.2. DPIs (Dry Powder Inhalers)
14.6.7.1.3. Propellant-free multi-dose spray inhalers.
14.6.7.2. Southeast Asia Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By Indication
14.6.7.2.1. Asthma
14.6.7.2.2. COPD
14.6.7.2.3. Others
14.6.7.3. Southeast Asia Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
14.6.7.3.1. Hospital Pharmacies
14.6.7.3.2. Retail Pharmacies
14.6.7.3.3. Online pharmacies
14.6.7.4. Southeast Asia Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By End User
14.6.7.4.1. Kids
14.6.7.4.2. Adults
14.6.7.5. Southeast Asia Smart Inhaler Technology Market Revenue (US$
Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By Inhaler Type
14.6.8.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
14.6.8.1.2. DPIs (Dry Powder Inhalers)
14.6.8.1.3. Propellant-free multi-dose spray inhalers.
14.6.8.2. Rest of Asia Pacific Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By Indication
14.6.8.2.1. Asthma
14.6.8.2.2. COPD
14.6.8.2.3. Others
14.6.8.3. Rest of Asia Pacific Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
14.6.8.3.1. Hospital Pharmacies
14.6.8.3.2. Retail Pharmacies
14.6.8.3.3. Online pharmacies
14.6.8.4. Rest of Asia Pacific Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By End User
14.6.8.4.1. Kids
14.6.8.4.2. Adults
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Inhaler Type
14.7.3. By Indication
14.7.4. By
Distribution Channel
14.7.5. By End
User
15. Middle East and Africa Smart Inhaler Technology Market
Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle
East and Africa Smart Inhaler Technology Market Revenue (US$ Mn)
15.2. Middle
East and Africa Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts,
By Inhaler Type
15.2.1. Breath-actuated
MDIs (Metered-Dose Inhalers)
15.2.2. DPIs
(Dry Powder Inhalers)
15.2.3. Propellant-free
multi-dose spray inhalers.
15.3. Middle
East and Africa Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts,
By Indication
15.3.1. Asthma
15.3.2. COPD
15.3.3. Others
15.4. Middle
East and Africa Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
15.4.1. Hospital
Pharmacies
15.4.2. Retail
Pharmacies
15.4.3. Online
pharmacies
15.5. Middle
East and Africa Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts,
By End User
15.5.1. Kids
15.5.2. Adults
15.6. Middle
East and Africa Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts,
By Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Inhaler Type
15.6.1.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
15.6.1.1.2. DPIs (Dry Powder Inhalers)
15.6.1.1.3. Propellant-free multi-dose spray inhalers.
15.6.1.2. Saudi Arabia Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Indication
15.6.1.2.1. Asthma
15.6.1.2.2. COPD
15.6.1.2.3. Others
15.6.1.3. Saudi Arabia Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
15.6.1.3.1. Hospital Pharmacies
15.6.1.3.2. Retail Pharmacies
15.6.1.3.3. Online pharmacies
15.6.1.4. Saudi Arabia Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By End User
15.6.1.4.1. Kids
15.6.1.4.2. Adults
15.6.2. UAE
15.6.2.1. UAE Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
15.6.2.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
15.6.2.1.2. DPIs (Dry Powder Inhalers)
15.6.2.1.3. Propellant-free multi-dose spray inhalers.
15.6.2.2. UAE Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
15.6.2.2.1. Asthma
15.6.2.2.2. COPD
15.6.2.2.3. Others
15.6.2.3. UAE Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.2.3.1. Hospital Pharmacies
15.6.2.3.2. Retail Pharmacies
15.6.2.3.3. Online pharmacies
15.6.2.4. UAE Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.2.4.1. Kids
15.6.2.4.2. Adults
15.6.3. Egypt
15.6.3.1. Egypt Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
15.6.3.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
15.6.3.1.2. DPIs (Dry Powder Inhalers)
15.6.3.1.3. Propellant-free multi-dose spray inhalers.
15.6.3.2. Egypt Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
15.6.3.2.1. Asthma
15.6.3.2.2. COPD
15.6.3.2.3. Others
15.6.3.3. Egypt Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.3.3.1. Hospital Pharmacies
15.6.3.3.2. Retail Pharmacies
15.6.3.3.3. Online pharmacies
15.6.3.4. Egypt Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.3.4.1. Kids
15.6.3.4.2. Adults
15.6.4. Kuwait
15.6.4.1. Kuwait Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
15.6.4.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
15.6.4.1.2. DPIs (Dry Powder Inhalers)
15.6.4.1.3. Propellant-free multi-dose spray inhalers.
15.6.4.2. Kuwait Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
15.6.4.2.1. Asthma
15.6.4.2.2. COPD
15.6.4.2.3. Others
15.6.4.3. Kuwait Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.4.3.1. Hospital Pharmacies
15.6.4.3.2. Retail Pharmacies
15.6.4.3.3. Online pharmacies
15.6.4.4. Kuwait Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.4.4.1. Kids
15.6.4.4.2. Adults
15.6.5. South
Africa
15.6.5.1. South Africa Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Inhaler Type
15.6.5.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
15.6.5.1.2. DPIs (Dry Powder Inhalers)
15.6.5.1.3. Propellant-free multi-dose spray inhalers.
15.6.5.2. South Africa Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Indication
15.6.5.2.1. Asthma
15.6.5.2.2. COPD
15.6.5.2.3. Others
15.6.5.3. South Africa Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
15.6.5.3.1. Hospital Pharmacies
15.6.5.3.2. Retail Pharmacies
15.6.5.3.3. Online pharmacies
15.6.5.4. South Africa Smart Inhaler Technology Market Revenue (US$ Mn)
and Forecasts, By End User
15.6.5.4.1. Kids
15.6.5.4.2. Adults
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Smart Inhaler Technology
Market Revenue (US$ Mn) and Forecasts, By Inhaler Type
15.6.6.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
15.6.6.1.2. DPIs (Dry Powder Inhalers)
15.6.6.1.3. Propellant-free multi-dose spray inhalers.
15.6.6.2. Rest of Middle East & Africa Smart Inhaler Technology
Market Revenue (US$ Mn) and Forecasts, By
Indication
15.6.6.2.1. Asthma
15.6.6.2.2. COPD
15.6.6.2.3. Others
15.6.6.3. Rest of Middle East & Africa Smart Inhaler Technology
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.6.6.3.1. Hospital Pharmacies
15.6.6.3.2. Retail Pharmacies
15.6.6.3.3. Online pharmacies
15.6.6.4. Rest of Middle East & Africa Smart Inhaler Technology
Market Revenue (US$ Mn) and Forecasts, By End User
15.6.6.4.1. Kids
15.6.6.4.2. Adults
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Inhaler Type
15.7.3. By Indication
15.7.4. By
Distribution Channel
15.7.5. By End
User
16. Latin America Smart Inhaler Technology Market Analysis and
Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin
America Smart Inhaler Technology Market Revenue (US$ Mn)
16.2. Latin
America Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By
Inhaler Type
16.2.1. Breath-actuated
MDIs (Metered-Dose Inhalers)
16.2.2. DPIs
(Dry Powder Inhalers)
16.2.3. Propellant-free
multi-dose spray inhalers.
16.3. Latin
America Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By Indication
16.3.1. Asthma
16.3.2. COPD
16.3.3. Others
16.4. Latin
America Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.4.1. Hospital
Pharmacies
16.4.2. Retail
Pharmacies
16.4.3. Online
pharmacies
16.5. Latin
America Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By End
User
16.5.1. Kids
16.5.2. Adults
16.6. Latin
America Smart Inhaler Technology Market Revenue (US$ Mn) and Forecasts, By
Country
16.6.1. Brazil
16.6.1.1. Brazil Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
16.6.1.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
16.6.1.1.2. DPIs (Dry Powder Inhalers)
16.6.1.1.3. Propellant-free multi-dose spray inhalers.
16.6.1.2. Brazil Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
16.6.1.2.1. Asthma
16.6.1.2.2. COPD
16.6.1.2.3. Others
16.6.1.3. Brazil Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.6.1.3.1. Hospital Pharmacies
16.6.1.3.2. Retail Pharmacies
16.6.1.3.3. Online pharmacies
16.6.1.4. Brazil Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.1.4.1. Kids
16.6.1.4.2. Adults
16.6.2. Argentina
16.6.2.1. Argentina Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Inhaler Type
16.6.2.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
16.6.2.1.2. DPIs (Dry Powder Inhalers)
16.6.2.1.3. Propellant-free multi-dose spray inhalers.
16.6.2.2. Argentina Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Indication
16.6.2.2.1. Asthma
16.6.2.2.2. COPD
16.6.2.2.3. Others
16.6.2.3. Argentina Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.6.2.3.1. Hospital Pharmacies
16.6.2.3.2. Retail Pharmacies
16.6.2.3.3. Online pharmacies
16.6.2.4. Argentina Smart Inhaler Technology Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.2.4.1. Kids
16.6.2.4.2. Adults
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By Inhaler Type
16.6.3.1.1. Breath-actuated MDIs (Metered-Dose Inhalers)
16.6.3.1.2. DPIs (Dry Powder Inhalers)
16.6.3.1.3. Propellant-free multi-dose spray inhalers.
16.6.3.2. Rest of Latin America Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By Indication
16.6.3.2.1. Asthma
16.6.3.2.2. COPD
16.6.3.2.3. Others
16.6.3.3. Rest of Latin America Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
16.6.3.3.1. Hospital Pharmacies
16.6.3.3.2. Retail Pharmacies
16.6.3.3.3. Online pharmacies
16.6.3.4. Rest of Latin America Smart Inhaler Technology Market Revenue
(US$ Mn) and Forecasts, By End User
16.6.3.4.1. Kids
16.6.3.4.2. Adults
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Inhaler Type
16.7.3. By Indication
16.7.4. By
Distribution Channel
16.7.5. By End
User
17. Competitive Benchmarking
17.1. Market
Share Analysis, 2021
17.2. Global
Presence and Growth Strategies
17.2.1. Mergers
and Acquisitions
17.2.2. Product
Launches
17.2.3. Investments
Trends
17.2.4. R&D
Initiatives
18. Player Profiles
18.1. adherium
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. Aptar
Group Inc. (Cohero Health Inc.)
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. AstraZeneca,
Inc.
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. BreatheSuite
Inc.
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. Cognita
Labs
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. Findair
Sp. z o. o.
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. GlaxoSmithKline
Plc
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. OPKO
Health Inc.
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. Philip
Morris International Inc. (Vectura Group Plc)
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. ResMed
Inc. (Propeller Health)
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Sensirion
AG
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business
Strategies
18.12. Teva
Pharmaceutical Industries Ltd.
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business Strategies
18.13. Other
Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
